AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Vical Receives U.S. government contract to manufacture Ebola vaccine.(Brief Article)

Vaccine Weekly

| August 28, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Vical, Inc., (VICL) announced that the company has been awarded a contract to manufacture clinical-grade supplies of an experimental DNA vaccine against Ebola for initial clinical development planned by the Dale and Betty Bumpers Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Vical's president and CEO, Vijay B. Samant, said, "Over the last several years, Vical has developed significant expertise and infrastructure, and has become recognized as a reliable manufacturer of clinical-grade (cGMP) plasmid DNA. We are pleased to support the VRC's Ebola vaccine program, which has potential for prevention of both the naturally occurring and weaponized forms. The beauty of using Vical's technology platform for such virulent agents is that development and production of vaccines do not involve any handling of the pathogen itself."

"Our colleagues at the VRC and other investigators have demonstrated in a variety of animal models that gene-based vaccines can induce protective immunity to lethal challenge by Ebola viruses," said Vical's chief scientific officer, David C. Kaslow, MD. "With the recent issuance of the 'two animal rule' by the FDA, a new path has emerged for demonstrating effectiveness of new products, such as Ebola vaccines, ...

Related articles from newspapers, magazines, journals, and more
Vical Begins Manufacturing SARS Vaccine for VRC.
Press release article from: PR Newswire October 13, 2003 700+ words
Vical Incorporated announced...Vaccine Research Center (VRC), National Institute...order is in addition to Vical's DNA vaccine manufacturing...prime contract with NIH. Vical's President and Chief...are pleased with the VRC's selection of our...
Vical and NIH Developing Ebola Vaccine.
Press release article from: PR Newswire November 18, 2003 700+ words
...vaccine for Ebola, based on Vical's patented gene delivery...Vaccine Research Center (VRC), National Institute of...clinical supplies manufactured by Vical under a manufacturing agreement for the VRC. Vical's President and Chief Executive...
Vical DNA Vaccine Technology Enters Phase 2 Clinical Trial for HIV.
Press release article from: PR Newswire October 11, 2005 700+ words
...Research Center (VRC) of the National...was manufactured by Vical. The vaccine incorporates...around the world. Vical has produced multiple DNA vaccines for the VRC against infectious...vector vaccine alone. Vical announced in June...against HIV for the VRC under a subcontract...
Vical DNA Delivery Technology Enters Clinical Trial for Therapeutic HIV Vaccine.
Press release article from: PR Newswire August 22, 2006 700+ words
...Research Center (VRC) of the National...was manufactured by Vical. The vaccine incorporates...against HIV in the VRC program. "Antiviral...Vijay B. Samant, Vical's President and...throughout the trial. Vical has produced multiple DNA vaccines for the VRC against infectious...
Vical to Manufacture DNA Vaccines for NIAID/NIH Vaccine Research Center.
Press release article from: PR Newswire May 12, 2003 700+ words
...this contract, the VRC will underwrite the...purification equipment in Vical's new manufacturing...of the agreement. Vical continues to manufacture...DNA vaccines for the VRC in its existing manufacturing...include whether the VRC will extend or terminate...agreement, whether Vical ...
Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce...
Press release article from: PR Newswire August 22, 2007 700+ words
...used in the trials was developed by VRC scientists and was manufactured by Vical. The adenoviral vector vaccine was developed by VRC in collaboration with GenVec Inc...adenoviral vector vaccine. About Vical Vical researches and develops biopharmaceutical...
Vical Receives DNA Vaccine Orders for National Institutes of Health.
Press release article from: PR Newswire February 9, 2004 700+ words
Vical Incorporated announced...Vaccine Research Center (VRC) at the National Institute...equipment (GFE) by the VRC in the Pacific Center...relationship with the VRC and SAIC-Frederick," said Vijay B. Samant, Vical's President and Chief...
Vical Announces Second-Quarter 2003 Financial Results.
Press release article from: PR Newswire July 31, 2003 700+ words
...development planned by the VRC, under a contract awarded...July 2003. In May 2003, Vical announced a contract to...bulk DNA vaccines for the VRC, with guaranteed minimum...of this contract, the VRC has agreed to finance...purification equipment in Vical's new manufacturing...
For more facts and information, see all results

Source: HighBeam Research, Vical Receives U.S. government contract to manufacture Ebola...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA